Did Merck & Co. act appropriately back in 1999 when it discovered the dangers of heart attack and stroke associated with its product Vioxx? A new article published in today’s NPR puts that question to the test by questioning three renown scientists who are authorities on heart disease and clinical studies about the VIGOR study. For more information about this article on the VIGOR study click here
@thumbnail.jpg "M. Brandon Smith")
A partner with Childers, Schlueter & Smith, LLC,, Brandon Smith has devoted his practice to pharmaceutical litigation, mass torts, products liability and serious personal injury. A frequent guest speaker at legal seminars all over the country—Brandon is focused on helping injured victims nationwide, however possible. Named a SuperLawyer again in 2019, he has also been called out as one of 10 Best Attorneys For Georgia by the American Institute Of Personal Injury Attorneys and a Top 100 Lawyer in Georgia by the National Trial Lawyers in 2019.
Comments for this article are closed.